SM

Swati Modi

Active Director Director DIN 08114079
DIN 08114079 First appointment Apr 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Swati Modi

Data last updated:

Swati Modi is a Director at Terapio Pharma Private Limited (since 2018). The company operates in Trading. Terapio Pharma Private Limited reported revenue of ₹19.8 Lakh (FY 2023).

DIN 08114079
Primary Designation Director
Industry Trading
First Appointment 19 Apr 2018
Oldest Company Age 12 yrs
Largest company Terapio Pharma Private Limited · ₹19.8 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Terapio Pharma Private Limited U24232MP2014PTC032708
Director19 Apr 20182014₹19.8 Lakh (FY 2023)Active

Board colleagues of Swati Modi

NameDINCompanyDesignation
Ambrish Rathore08114078Terapio Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Terapio Pharma Private Limited
Premium access

Shareholding and investment profile for Swati Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Modi

Swati Modi currently holds 1 directorship: Terapio Pharma Private Limited (Director, since 19 Apr 2018, revenue ₹19.8 Lakh (FY 2023)).

Swati Modi was first appointed on 19 Apr 2018 as Director at Terapio Pharma Private Limited.

The current boards of Swati Modi's companies include Ambrish Rathore (Terapio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available